Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries NKGen Biotech, Inc. - Common Stock (NQ: NKGN ) 0.3822 UNCHANGED Streaming Delayed Price Updated: 3:54 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about NKGen Biotech, Inc. - Common Stock < Previous 1 2 3 Next > Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket September 17, 2024 Via Benzinga NKGen Biotech’s Positive Phase 1 Clinical Data in Moderate Alzheimer’s Disease Advances Troculeucel into Phase 2 with First Patient Dosed in Phase 1/2a Trial September 12, 2024 From NKGen Biotech Via GlobeNewswire NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 03, 2024 From NKGen Biotech Via GlobeNewswire NKGN Stock Earnings: NKGen Biotech Reported Results for Q1 2024 May 21, 2024 NKGen Biotech just reported results for the first quarter of 2024. Via InvestorPlace NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report August 22, 2024 From NKGen Biotech, Inc. Via GlobeNewswire NKGen Biotech Presents New Positive SNK01 Biomarker Data at the 2024 Alzheimer’s Association International Conference July 30, 2024 From NKGen Biotech Via GlobeNewswire Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket July 22, 2024 Via Benzinga Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session July 18, 2024 Via Benzinga Barclays Just Raised Its Price Target on Intuitive Surgical (ISRG) Stock July 18, 2024 Intuitive Surgical stock is falling on Thursday even after shares of ISRG got an increased price target from Barclays analysts. Via InvestorPlace WBD Stock Pops as Warner Bros. Considers Streaming Spinoff July 18, 2024 Warner Bros. stock is rising on Thursday as reports about a potential spinoff of its streaming division embolden WBD investors. Via InvestorPlace Why Is NKGen Biotech (NKGN) Stock Up 18% Today? July 18, 2024 NKGen Biotech stock is up Thursday as NKGN holders react to plans for a presentation at the Alzheimer’s Association International Conference. Via InvestorPlace Why NKGen Biotech (NKGN) Stock Is Skyrocketing July 18, 2024 NKGen Biotech shares are trading higher by 32.5% Thursday morning. The company announced it will present new SNK01 biomarker data at the Alzheimer's Association International Conference. Via Benzinga NKGen Biotech to Present New Positive SNK01 Clinical Trial Biomarker Data at the 2024 Alzheimer’s Association International Conference July 18, 2024 From NKGen Biotech Via GlobeNewswire NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors July 15, 2024 From NKGen Biotech Via GlobeNewswire NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024 June 12, 2024 From NKGen Biotech Via GlobeNewswire Spotlighting Unexplored Stocks in Focus: NKGN, INBS, BTBT, PRSO, MGOL May 24, 2024 Via AB Newswire Topics Artificial Intelligence Exposures Artificial Intelligence Dow Falls Over 150 Points; Sohu Posts Q1 Loss May 20, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 20, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session May 20, 2024 Via Benzinga Nasdaq Surges 100 Points; Wix.com Shares Jump Following Q1 Results May 20, 2024 Via Benzinga NKGN Stock Alert: The Alzheimer’s News That Has NKGen Biotech Soaring Today May 20, 2024 NKGen Biotech stock is up with heavy trading of NKGN shares alongside approval for its Phase 2 clinical trial of its Alzheimer’s treatment. Via InvestorPlace Why NKGen Biotech Stock Is Moving Higher Monday May 20, 2024 NKGen Biotech shares are trading higher Monday after the company's SNK01 NK Cell Therapy was cleared to begin a Phase 2 trial in Alzheimer's disease. Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 02, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session April 29, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session April 26, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 23, 2024 Via Benzinga What's Going On With Nano-Cap NKGen Biotech Stock On Monday? April 22, 2024 Latest on NKGen Biotech Inc (NASDAQ: NKGN) as shares surge 25.2% on high volume. Insights into NK cell therapy for neurodegenerative diseases. Developments in Parkinson's and Alzheimer's treatments. Via Benzinga Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session April 22, 2024 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.